Cellular Pathology Referrals - Cambridge University Hospitals NHST

The procurement process titled "Cellular Pathology Referrals - Cambridge University Hospitals NHST" is being administered by the Gateshead Health NHS Foundation Trust, a regional or local authority. This procurement falls under the services category, specifically targeting services provided by medical laboratories, and is located in the United Kingdom. As of the most recent update on 8th August 2025, the procurement is in the Tender Update stage, with the contract having been awarded on 25th July 2025.

The contract is for a period from 1st April 2025 to 31st March 2028 and holds a value of £7500. The procurement method used is a limited procedure, employing a direct award process under the Health Care Services (Provider Selection Regime) Regulations 2023, and does not fall under the Procurement Act 2023. This tender presents growth opportunities for businesses that specialise in healthcare services, particularly those involved in cellular pathology and laboratory diagnostics.

Large-scale organisations like the Cambridge University Hospital NHS Trust, which was chosen as the supplier, will find this tender fitting. The Provider Selection Regime allows for direct awards without a prior competition call, which could benefit businesses with established reputations and connections in providing specialty medical services. Companies with UKAS accreditation and the capability to offer consultations, clinical advice, and timely results within regulatory guidelines will be well-suited for similar opportunities.